Literature DB >> 1637883

Erythropoietin levels in patients depositing autologous blood in short intervals.

A Lorentz1, K U Eckardt, P M Osswald, J R Duchow.   

Abstract

Plasma immunoreactive erythropoietin (EPO) concentrations were studied in ten patients (7 men, 3 women) predonating autologous blood for hip arthroplasty. Donations were scheduled on day 1, 3, 7, 14 (and 21 if four units could not be donated previously). A predonation hemoglobin concentration of 11 g/dl was required. The donations led to a decline of the hemoglobin concentration from 14.1 +/- 1.0 g/dl (X +/- SD) prior to donation to 11.0 +/- 0.9 g/dl on day 15. EPO concentration prior to donation was 17.6 +/- 2.6 mU/ml. Each phlebotomy was followed by a rise in EPO levels that reached a peak concentration within 1 day. The highest concentration (35.8 +/- 15.0 mU/ml) was measured on day 16. The peak concentration was followed by a plateau at lower, although still elevated levels after the first and second donation, and by a slow, continuous decline after the third and fourth donation. This particular time course is similar to that during weekly donations [15]. The time integral of the EPO concentration during the first 3 weeks, however, was greater in the present study. This increased availability of EPO early during donation may lead to a more efficient stimulation of erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637883     DOI: 10.1007/bf01695472

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  20 in total

Review 1.  THE EFFECTS OF HEMORRHAGE ON BODY COMPOSITION.

Authors:  F D MOORE
Journal:  N Engl J Med       Date:  1965-09-09       Impact factor: 91.245

2.  Prediction of blood volume in normal human adults.

Authors:  Samuel B Nadler; John H Hidalgo; Ted Bloch
Journal:  Surgery       Date:  1962-02       Impact factor: 3.982

3.  Accelerated erythropoiesis: the hidden benefit of autologous donation.

Authors:  E Levine; A Rosen; L Sehgal; S Gould; H Sehgal; G Moss
Journal:  Transfusion       Date:  1990-05       Impact factor: 3.157

4.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

Authors:  L T Goodnough; S Rudnick; T H Price; S K Ballas; M L Collins; J P Crowley; M Kosmin; M S Kruskall; B A Lenes; J E Menitove
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

Review 5.  The mechanism of action of erythropoietin.

Authors:  J L Spivak
Journal:  Int J Cell Cloning       Date:  1986-05

6.  Europium as a label in time-resolved immunofluorometric assays.

Authors:  I Hemmilä; S Dakubu; V M Mukkala; H Siitari; T Lövgren
Journal:  Anal Biochem       Date:  1984-03       Impact factor: 3.365

7.  Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors.

Authors:  T S Kickler; J L Spivak
Journal:  JAMA       Date:  1988-07-01       Impact factor: 56.272

8.  Predeposit autologous blood transfusions in patients undergoing irradiation and radical cystectomy.

Authors:  D A Swanson; R K Lo; B Lichtiger
Journal:  J Urol       Date:  1983-11       Impact factor: 7.450

9.  Decline of erythropoietin formation at continuous hypoxia is not due to feedback inhibition.

Authors:  K U Eckardt; J Dittmer; R Neumann; C Bauer; A Kurtz
Journal:  Am J Physiol       Date:  1990-05

10.  Serial immunoreactive erythropoietin levels in autologous blood donors.

Authors:  A Lorentz; A Jendrissek; K U Eckardt; M Schipplick; P M Osswald; A Kurtz
Journal:  Transfusion       Date:  1991-09       Impact factor: 3.157

View more
  2 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

2.  Perioperative plasma erythropoietin levels in hip arthroplasty.

Authors:  A Lorentz; K U Eckardt; P M Osswald; C Kruse
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.